Adults with overweight or obesity who received once-weekly ecnoglutide, a novel GLP-1 receptor agonist, had superior and sustained reductions in body weight compared with placebo, according to data ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared with placebo in patients with overweight or obesity with or without ...

In this video, Paolo F. Caimi, MD, MBA, staff physician at Cleveland Clinic, discusses the phase 2/3 WaveLINE-003 trial of patients with relapsed/refractory diffuse B-cell lymphoma.Results of the ...

An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with ...

A coalition of health care organizations, called the Alliance for Healthcare from the Eye, is pushing for increased adoption ...

Among adults with episodic migraine, fasting for 5 to 6 hours a day was linked to 49% higher odds of experiencing a same-day ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

Researchers have provided more evidence that mpox virus can be passed from a pregnant mother to her child. There remain ...

In this exclusive Healio Video Perspective from Kiawah Eye, P. Dee Stephenson, MD, FACS, discusses toric IOL rotation and ...

Opioid overdose deaths continued to rise among adolescents and young adults during a recent 5-year period, and synthetic ...